Quick Facts at a Glance
- Recall Date
- January 26, 2026
- Hazard Level
- HIGH
- Brand
- F.H. INVESTMENTS, Inc.
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- F.H. INVESTMENTS, Inc.
- Product type
- Testosterone and Anastrozole Pellet
- Model numbers
- Lot#: 254000104, Exp. 05/27/2026
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
January 26, 2026
Reported by FDA DRUG
February 18, 2026
RecallRadar source check
February 25, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Presence of Foreign substance - potential presence of metal particulate matter
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact F.H. INVESTMENTS, Inc. (dba Asteria Health) or your healthcare provider for guidance. Notification method: Letter
About This Product
This product is a sterile pellet that combines testosterone and anastrozole, primarily used for hormone therapy. Consumers purchase it to manage conditions related to low testosterone levels.
Why This Is Dangerous
The hazard arises from the potential presence of metal particulate matter, which can pose serious health risks if ingested or injected. This contamination can lead to adverse health effects.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers affected by this recall face potential health risks and should cease use immediately. They may also experience inconvenience in managing their health conditions while seeking alternatives.
Practical Guidance
How to identify if yours is affected
- Check the lot number on your product.
- Verify the expiration date listed as May 27, 2026.
- Contact your healthcare provider if unsure about product safety.
Where to find product info
The lot number and expiration date can usually be found on the product packaging or label.
What timeline to expect
Expect a refund processing timeline of approximately 4-6 weeks after returning the product.
If the manufacturer is unresponsive
- Keep a record of all communications with the company.
- Consider escalating your complaint to the FDA if no response is received.
How to prevent similar issues
- Look for products with clear safety certifications.
- Check for any reported recalls before purchase.
- Consult healthcare providers for trusted brands.
Documentation advice
Document all correspondence with the manufacturer and keep copies of any receipts or notifications related to the recall.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
The recall affects testosterone 100mg and anastrozole 4mg sterile pellets, NDC: 79559-4104-01. These products were distributed nationwide in the USA. The lot number for the affected products is 254000104, with an expiration date of May 27, 2026.
Key Facts
- Recall date: January 26, 2026
- Hazard: Potential metal contamination
- Consumers should stop using immediately
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.